Karsten Voermann - Goodrx Holdings Chief Officer
| GDRX Stock | USD 4.95 0.11 2.27% |
Executive
Karsten Voermann is Chief Officer of Goodrx Holdings
| Age | 55 |
| Phone | 855 268 2822 |
| Web | https://www.goodrx.com |
Karsten Voermann Latest Insider Activity
Tracking and analyzing the buying and selling activities of Karsten Voermann against Goodrx Holdings stock is an integral part of due diligence when investing in Goodrx Holdings. Karsten Voermann insider activity provides valuable insight into whether Goodrx Holdings is net buyers or sellers over its current business cycle. Note, Goodrx Holdings insiders must abide by specific rules, including filing SEC forms every time they buy or sell Goodrx Holdings'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Karsten Voermann over two weeks ago Disposition of 89292 shares by Karsten Voermann of Goodrx Holdings subject to Rule 16b-3 | ||
Karsten Voermann over six months ago Acquisition by Karsten Voermann of 54064 shares of Goodrx Holdings subject to Rule 16b-3 | ||
Karsten Voermann over six months ago Acquisition by Karsten Voermann of 357168 shares of Goodrx HoldingsInc subject to Rule 16b-3 | ||
Karsten Voermann over a year ago Sale by Karsten Voermann of 7842 shares of Goodrx HoldingsInc |
Goodrx Holdings Management Efficiency
The company has return on total asset (ROA) of 0.0421 % which means that it generated a profit of $0.0421 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0206) %, meaning that it created substantial loss on money invested by shareholders. Goodrx Holdings' management efficiency ratios could be used to measure how well Goodrx Holdings manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Rana Strellis | GE HealthCare Technologies | N/A | |
| Amanda Flanders | Health Catalyst | N/A | |
| Sheila MBA | Certara | N/A | |
| Drew Garner | Accolade | N/A | |
| Michael JD | HealthStream | 49 | |
| Holly Rimmasch | Health Catalyst | N/A | |
| Linda Llewelyn | Health Catalyst | 58 | |
| Frank Esq | GE HealthCare Technologies | 60 | |
| James Hart | Progyny | N/A | |
| Jonathan Weinberg | Evolent Health | 53 | |
| Daniel Szot | Simulations Plus | N/A | |
| Jennifer JD | Doximity | 57 | |
| Jennifer Presnell | Simulations Plus | N/A | |
| MD FAAFP | American Well Corp | N/A | |
| John III | Certara | 52 | |
| Alexander Wong | 10X Genomics | N/A | |
| Richard CPA | Definitive Healthcare Corp | 56 | |
| Meredith Dixon | American Well Corp | N/A | |
| Thomas Bartrum | Privia Health Group | 56 | |
| Yvonne Esq | Schrodinger | 53 | |
| Janet MD | Progyny | N/A | |
Management Performance
| Return On Equity | -0.0206 | ||||
| Return On Asset | 0.0421 |
Goodrx Holdings Leadership Team
Elected by the shareholders, the Goodrx Holdings' board of directors comprises two types of representatives: Goodrx Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Goodrx. The board's role is to monitor Goodrx Holdings' management team and ensure that shareholders' interests are well served. Goodrx Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Goodrx Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Bansi Nagji, President Healthcare | ||
| Mike Walsh, President Marketplace | ||
| Douglas Hirsch, Cofounder Director | ||
| Andrew Slutsky, Chief Officer | ||
| Nitin Shingate, Chief Officer | ||
| Babak Azad, Chief Communications | ||
| Whitney Notaro, Vice Relations | ||
| Scott Wagner, Principal Officer | ||
| Trevor Bezdek, Cofounder Chairman | ||
| Wendy Barnes, Chief Officer | ||
| Vina Leite, Chief Officer | ||
| Karsten Voermann, Chief Officer | ||
| Aubrey Reynolds, Director Relations | ||
| Gracye Cheng, General Secretary | ||
| Ryan Sullivan, Chief Officer | ||
| Romin Nabiey, Interim Officer | ||
| Justin Fengler, Senior Operations | ||
| Raj Beri, Chief Officer |
Goodrx Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Goodrx Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0206 | ||||
| Return On Asset | 0.0421 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | 0.10 % | ||||
| Current Valuation | 1.98 B | ||||
| Shares Outstanding | 104.27 M | ||||
| Shares Owned By Insiders | 12.00 % | ||||
| Shares Owned By Institutions | 68.61 % | ||||
| Number Of Shares Shorted | 7.58 M | ||||
| Price To Book | 2.68 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Goodrx Stock Analysis
When running Goodrx Holdings' price analysis, check to measure Goodrx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Goodrx Holdings is operating at the current time. Most of Goodrx Holdings' value examination focuses on studying past and present price action to predict the probability of Goodrx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Goodrx Holdings' price. Additionally, you may evaluate how the addition of Goodrx Holdings to your portfolios can decrease your overall portfolio volatility.